Diomed develops pharmaceutical laser for Scotia:
This article was originally published in Clinica
Executive Summary
Diomed is developing a laser activator for Scotia Pharmaceuticals' photosensitising drug, Foscan. The non-exclusive agreement will give Scotia access to diode laser technology during the development and commercialisation phase of Foscan, a synthetic photodynamic agent that releases oxygen under laser excitement.